Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

May 3, 2004

Date of Report (date of earliest event reported)

 


 

CUTERA, INC.

(Exact name of Registrant as specified in its charter)

 

State of Delaware   000-50644   77-0492262
(State or other jurisdiction of   (Commission File Number)   (I.R.S. Employer
incorporation or organization)       Identification Number)

 

3240 Bayshore Blvd.

Brisbane, California 94005

(Address of principal executive offices)

 

(415) 657-5500

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 


 


Item 7. Financial Statements and Exhibits

 

(c) Exhibits

 

 

Exhibit No.

  

Description


99.1    Press Release, dated as of May 3, 2004.

 

 

Item 12. Results of Operations and Financial Condition.

 

On May 3, 2004, we issued a press release announcing our first quarter 2004 results. The press release is attached hereto as Exhibit 99.1. This Exhibit is not “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), but is instead furnished. The Exhibit is not incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 


SIGNATURES

 

Pursuant to the requirements if the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

CUTERA, INC.
By:   /s/    Kevin P. Connors
   
   

Kevin P. Connors

    President and Chief Executive Officer

 

Date: May 3, 2004

 

Press Release dated May 3, 2004

EXHIBIT 99.1

 

LOGO

 

FOR IMMEDIATE RELEASE

 

CONTACTS:

 

Cutera, Inc.

Ron Santilli

Chief Financial Officer

415-657-5500

 

Investor Relations

John Mills or Tom Ryan

Integrated Corporate Relations, Inc.

310-395-2215

jmills@icrinc.com

 

CUTERA REPORTS FIRST QUARTER 2004 RESULTS

 

·    Revenue Increases 76% to $11.6 Million

 

·    Earnings per diluted share of $0.02

 

Brisbane, California, May 3, 2004 – Cutera, Inc. (Nasdaq: CUTR), a leading manufacturer of laser and other light-based aesthetic systems, today reported financial results for the first quarter ended March 31, 2004.

 

First quarter revenue was $11.6 million, a 76% increase over the $6.6 million recorded in the same period last year. Net income for the first quarter was $221,000, or $0.02 per diluted share, compared to a net loss of $72,000 or $0.04 per diluted share, reported in the first quarter of 2003. Included in the first quarter results is $372,000 of pre-tax, non-cash, stock-based compensation charges, compared to charges of $220,000 in the first quarter of 2003. First quarter results also reflect G&A costs associated with a facilities move, IPO accounting fees, and settlement of the Allied Health lawsuit.

 

“We are very pleased with our first quarter results, particularly as a newly public company,” said Kevin Connors, President and CEO. “As consumer demand continues to grow for non-invasive aesthetic treatments, dermatologists, plastic surgeons and other emerging physician groups are turning to Cutera for our high performance, expandable technology platforms. We believe the market for our products is significant, as we have recently experienced exciting growth in the primary care physician segment. The shift in


product mix towards our premier offering is evidence that the market recognizes the value and performance of our versatile technology platforms and our multi-application systems.”

 

Based on the current outlook, Cutera believes that second quarter revenue will be approximately $11.8 million with corresponding earnings per diluted share of $0.03. Weighted average shares for diluted EPS in the second quarter are estimated to increase by 3.8 million shares to approximately 13.2 million shares, primarily resulting from the issuance of shares due to the Company’s IPO and the exercise in full of the over-allotment of shares by the underwriters. For the full year, Cutera expects revenue of $49.5 to $50.5 million and earnings per diluted share of $0.15 to $0.17.

 

Conference Call

 

Cutera, Inc. will host a conference call today, May 3, 2004, to discuss its first quarter 2004 financial results at 2:00 p.m. PST. Participating in the call will be Kevin Connors, President and Chief Executive Officer, Ron Santilli, Chief Financial Officer, and Matt Lucero, General Counsel. The earnings release will be broadcast live over the Internet hosted at the Investor Relations section of the company’s website at http://www.cutera.com and will be archived online within one hour of the completion of the conference call. In addition, you may call 800-633-8556. A telephonic playback will be available from 3:00 p.m. PST on May 3 through 11:59 p.m. PST on May 18th, 2004 by calling 800-633-8284 to access the playback; pass code is 21193787.

 

About Cutera, Inc.

 

CuteraTM designs, develops, manufactures and markets the CoolGlide® family of products for use in laser and other light-based aesthetic applications. The original CoolGlide CVTM provides permanent hair reduction on all skin types. The second generation CoolGlide Excel® incorporated features that added the capability to treat a variety of vascular lesions, which include facial telangiectasia, spider and reticular leg veins. The CoolGlide VantageTM added non-ablative skin therapy to the range of applications offered by the system. The CoolGlide XeoTM added the capability to treat pigmented lesions. The new Xeo SATM offers a platform for next-generation pulsed light treatment, with an upgrade path to the CoolGlide Xeo.

 

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning Cutera’s financial results for the first quarter of 2004, as well as its expectations regarding financial results for the second quarter of 2004 and for the 2004 fiscal year, are forward-looking statements within the meaning of the Safe Harbor. Forward-looking statements are based on management’s current, preliminary, expectations and are subject to risks and uncertainties, which may cause Cutera’s actual results to differ materially from the statements contained herein. Cutera’s first quarter financial results, as discussed in this release, are preliminary and unaudited, and subject to adjustment. Estimates of second quarter and year-end financial results are subject to a number of assumptions regarding the future operation of our business. Further information on potential risk factors that could affect Cutera’s business and its financial results are detailed in its filings with the Securities and Exchange Commission, including its Registration Statement on Form S-1 declared effective on March 30, 2004. Undue reliance should not be placed on forward-looking statements, especially guidance on future financial performance, which speaks only as of the date they are made. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, May 3, 2004, or to reflect the occurrence of unanticipated events.

 

2


CUTERA, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

 

     March 31,
2004
(unaudited)


  

December 31,
2003

(note)


Assets

             

Current assets:

             

Cash and cash equivalents

   $ 10,978    $ 10,290

Restricted cash

     250      250

Accounts receivable, net

     6,683      7,597

Inventory

     2,786      2,239

Current portion of deferred tax asset

     2,042      1,699

Other current assets

     1,051      879
    

  

Total current assets

     23,790      22,954

Property and equipment, net

     884      734

Intangibles, net

     439      453

Deferred tax asset, net of current portion

     46      57
    

  

Total assets

   $ 25,159    $ 24,198
    

  

Liabilities, Redeemable Convertible Preferred Stock and Stockholders’ Equity

             

Liabilities:

             

Accounts payable

   $ 2,220    $ 1,915

Accrued liabilities

     6,253      5,709

Deferred revenue

     1,033      1,125
    

  

Total current liabilities

     9,506      8,749

Deferred rent

     312      —  

Deferred revenue, net of current portion

     289      202
    

  

Total liabilities

     10,107      8,951
    

  

Redeemable convertible preferred stock and stockholders’ equity

     15,052      15,247
    

  

Total liabilities and stockholders’ equity

   $ 25,159    $ 24,198
    

  

 

(note): Derived from audited consolidated financial statements at that date.

 

3


CUTERA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

 

    

Three Months Ended

March 31,


 
     2004

     2003

 

Net revenue:

   $ 11,580      $ 6,596  

Cost of revenue(1)

     3,647        2,233  
    

    


Gross profit

     7,933        4,363  
    

    


Operating expenses:

                 

Sales and marketing

     4,279        2,489  

Research and development

     959        751  

General and administrative

     2,069        1,082  

Amortization of deferred stock compensation (1)

     321        178  
    

    


Total operating expenses

     7,628        4,500  
    

    


Income (loss) from operations

     305        (137 )

Interest and other income, net

     58        18  
    

    


Income (loss) before income taxes

     363        (119 )

Provision (benefit) for income taxes

     142        (47 )
    

    


Net income (loss)

   $ 221      $ (72 )
    

    


Net income (loss) per share:

                 

Basic

   $ 0.10      $ (0.04 )
    

    


Diluted

   $ 0.02      $ (0.04 )
    

    


Weighted-average number of shares used in per share calculations:

                 

Basic

     2,292        2,000  
    

    


Diluted

     9,411        2,000  
    

    


(1) Amortization of deferred stock compensation related to:

                 

Cost of revenue

   $ 51      $ 42  
    

    


Operating expenses:

                 

Sales and marketing

     83        28  

Research and development

     99        72  

General and administrative

     139        78  
    

    


     $ 321      $ 178  
    

    


 

4